We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current C1OO34 market cap is 2.92B. The company's latest EPS is USD 5.9406 and P/E is 55.78.
Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 930.2M | 927.1M | 931.6M | 942.6M | 1B |
Operating Income | 151.6M | 135.7M | 153.1M | 161.7M | 192.5M |
Net Income | 85.3M | 84.5M | 81.2M | 88.9M | 104.7M |
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.65B | 2.43B | 2.92B | 3.31B | 3.59B |
Operating Income | 527.7M | 311.8M | 505.8M | 507.6M | 533.1M |
Net Income | 466.7M | 238.4M | 2.94B | 385.8M | 294.2M |
Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 11.7B | 11.66B | 12.03B | 12.05B | 12.11B |
Total Liabilities | 4.17B | 4.11B | 4.34B | 4.24B | 4.18B |
Total Equity | 7.53B | 7.55B | 7.7B | 7.8B | 7.93B |
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 6.27B | 6.74B | 9.61B | 11.49B | 11.66B |
Total Liabilities | 2.65B | 2.91B | 2.66B | 4.32B | 4.11B |
Total Equity | 3.63B | 3.82B | 6.94B | 7.17B | 7.55B |
Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 433.3M | 607.5M | 122.7M | 233.7M | 441.2M |
Investing | -288.2M | -449M | -324.1M | -398.9M | -523M |
Financing | -167.4M | -173.9M | 212.3M | 155.2M | 67.6M |
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 713.2M | 486.6M | 738.6M | 692.4M | 607.5M |
Investing | -351.3M | -364.5M | -450.3M | -1.83B | -449M |
Financing | -351.4M | -95.5M | -311.4M | 1.19B | -173.9M |
Market Cap | 2.92B |
Price to Earnings Ratio | 55.78 |
Price to Sales Ratio | 4.57 |
Price to Cash Ratio | 135.84 |
Price to Book Ratio | 2.17 |
Dividend Yield | - |
Shares Outstanding | 49.52M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 24 |
52 Week Change | 469.00% |
52 Week High | 61.92 |
52 Week Low | 10.3406 |
Spread (Intraday) | 0.48 (0.82%) |
Company Name | Cooper Companies Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.coopercos.com |
Industry | ophthalmic goods (3851) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions